Maa: Euroopan unioni
Kieli: englanti
Lähde: EMA (European Medicines Agency)
sulphur hexafluoride
Bracco International B.V.
V08DA04
sulphur hexafluoride
Contrast media
Ultrasonography; Echocardiography
This medicinal product is for diagnostic use only.SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio.SonoVue should only be used in patients where study without contrast enhancement is inconclusive.EchocardiographySonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.Doppler of macrovasculatureSonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries in adult patients by improving the Doppler signal to noise ratio.SonoVue increases the quality of the Doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment in adult patients.Doppler of microvasculatureSonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography in adult patients leading to more specific lesion characterisation.Ultrasonography of excretory urinary tractSonoVue is indicated for use in ultrasonography of the excretory tract in paediatric patients from newborn to 18 years to detect vesicoureteral reflux. For the limitation in the interpretation of a negative urosonography.
Revision: 20
Authorised
2001-03-26
19 B. PACKAGE LEAFLET 20 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SONOVUE 8 MICROLITRES/ML POWDER AND SOLVENT FOR DISPERSION FOR INJECTION sulphur hexafluoride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What SonoVue is and what it is used for 2. What you need to know before you are given SonoVue 3. How SonoVue is given 4. Possible side effects 5. How to store SonoVue 6. Contents of the pack and other information 1. WHAT SONOVUE IS AND WHAT IT IS USED FOR SonoVue is for diagnostic use only. SonoVue is an ultrasound contrast agent that contains tiny bubbles filled with a gas called sulphur hexafluoride. If you are an adult, SonoVue helps to obtain clearer ultrasound pictures of your heart, your blood vessels and/or tissues of the liver and breast. SonoVue helps to obtain clearer pictures of the urinary tract in children. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN SONOVUE DO NOT USE SONOVUE: - If you are allergic to sulphur hexafluoride or any of the other ingredients of this medicine (listed in section 6). - If you have been told you have a right-to-left heart shunt. - If you have severe pulmonary hypertension (pulmonary artery pressure > 90mmHg). - If you have uncontrolled hypertension. - If you have adult respiratory distress syndrome (a severe, medical condition characterized by widespread inflammation in the lungs). - If you have been told not to take dobutamine (medicine that stimulates the heart) due to your severe heart disease. WARNINGS AND PRECAUTIONS Please tell your doctor if in the past 2 days you h Lue koko asiakirja
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT SonoVue 8 microlitres/mL powder and solvent for dispersion for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each mL of the dispersion contains 8 µL sulphur hexafluoride microbubbles, equivalent to 45 micrograms. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Powder and solvent for dispersion for injection. White powder Clear, colourless solvent 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for diagnostic use only. SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio. SonoVue should only be used in patients where study without contrast enhancement is inconclusive. Echocardiography SonoVue is a transpulmonary echocardiographic contrast agent for use in adult patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation. Doppler of macrovasculature SonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries in adult patients by improving the Doppler signal to noise ratio. SonoVue increases the quality of the Doppler flow image and the duration of clinically-useful signal enhancement in portal vein assessment in adult patients. Doppler of microvasculature SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography in adult patients leading to more specific lesion characterisation. Ultrasonography of excretory urinary tract SonoVue is indicated for use in ultrasonography of the excretory tract in paediatric patients from newborn to 18 years to detect vesicoureteral reflux. For the limitation in the interpretation of a negative urosonography, see section 4.4. and 5.1. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION This product should only be u Lue koko asiakirja